BrightSpring Health Services, Inc. (NASDAQ:BTSG) Shares Purchased by Federated Hermes Inc.

Federated Hermes Inc. raised its position in BrightSpring Health Services, Inc. (NASDAQ:BTSG) by 80.2% during the 4th quarter, HoldingsChannel.com reports. The firm owned 572,436 shares of the company’s stock after acquiring an additional 254,811 shares during the period. Federated Hermes Inc.’s holdings in BrightSpring Health Services were worth $9,749,000 at the end of the most recent quarter.

Several other hedge funds have also made changes to their positions in the company. Virtu Financial LLC acquired a new stake in shares of BrightSpring Health Services during the 3rd quarter worth about $522,000. JPMorgan Chase & Co. increased its position in shares of BrightSpring Health Services by 275.2% during the third quarter. JPMorgan Chase & Co. now owns 163,618 shares of the company’s stock valued at $2,402,000 after acquiring an additional 120,005 shares during the last quarter. Legato Capital Management LLC raised its stake in shares of BrightSpring Health Services by 40.0% in the 4th quarter. Legato Capital Management LLC now owns 66,910 shares of the company’s stock valued at $1,139,000 after acquiring an additional 19,120 shares during the period. SG Americas Securities LLC lifted its holdings in shares of BrightSpring Health Services by 50.9% in the 4th quarter. SG Americas Securities LLC now owns 37,000 shares of the company’s stock worth $630,000 after acquiring an additional 12,486 shares during the last quarter. Finally, Barclays PLC lifted its holdings in shares of BrightSpring Health Services by 22.2% in the 3rd quarter. Barclays PLC now owns 393,725 shares of the company’s stock worth $5,780,000 after acquiring an additional 71,633 shares during the last quarter.

Analyst Ratings Changes

BTSG has been the topic of a number of research analyst reports. UBS Group boosted their target price on BrightSpring Health Services from $22.00 to $30.00 and gave the company a “buy” rating in a research report on Wednesday, January 29th. Morgan Stanley increased their target price on BrightSpring Health Services from $19.00 to $20.00 and gave the stock an “overweight” rating in a research note on Tuesday, December 17th. Finally, CJS Securities began coverage on BrightSpring Health Services in a research report on Thursday, December 12th. They issued an “outperform” rating and a $27.00 target price for the company. One equities research analyst has rated the stock with a hold rating and nine have given a buy rating to the company’s stock. According to data from MarketBeat, the company presently has an average rating of “Moderate Buy” and an average target price of $21.67.

BrightSpring Health Services Price Performance

Shares of NASDAQ BTSG opened at $17.41 on Friday. The company has a debt-to-equity ratio of 1.63, a current ratio of 1.35 and a quick ratio of 0.97. The company has a market cap of $3.05 billion, a price-to-earnings ratio of -66.96 and a beta of 2.02. The stock’s 50-day moving average is $19.06 and its two-hundred day moving average is $18.27. BrightSpring Health Services, Inc. has a 1-year low of $9.98 and a 1-year high of $24.82.

BrightSpring Health Services Profile

BrightSpring Health Services, Inc operates a home and community-based healthcare services platform in the United States. The company's platform focuses on delivering pharmacy and provider services, including clinical and supportive care in home and community settings to Medicare, Medicaid, and insured populations.